Vevo
Shreshth Gandhi has extensive work experience in the field of machine learning and biomedical engineering. Shreshth is currently working as a Principal ML Scientist at Vevo Therapeutics since November 2023. Prior to that, they held various roles at Deep Genomics, including Associate Director, Machine Learning, Machine Learning Lead, and Lead Scientist, and Research Scientist. Shreshth also served as a Machine Learning Research Intern at Deep Genomics in 2017. In addition, they have been a member of the Industry Advisory Committee at the School of Biomedical Engineering at UBC since February 2021.
Shreshth Gandhi earned a Bachelor of Technology (B.Tech.) in Electrical Engineering from the Indian Institute of Technology, Kanpur, from 2011 to 2015. Shreshth then pursued a Master of Science (M.Sc.) degree in Machine Learning and Genomics from the University of Toronto, from 2015 to 2017. Additionally, Shreshth has obtained a certification in MaRS Momentum Leadership Foundations from MaRS Discovery District in 2022.
This person is not in any offices
Vevo
1 followers
Vevo Therapeutics is a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients. The company’s Mosaic platform is the first to make in vivo data generation scalable, with single-cell precision, to capture in vivo context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays. Vevo is using Mosaic to build the world’s largest in vivo atlas of how drugs interact with patient cells and training AI models on its data to find novel targets and drugs undetectable by other technologies. Located in San Francisco, CA, Vevo was founded by a team of inventors and thought leaders who have discovered drugs for “undruggable” targets and invented novel methods in genomics, computational biology, and chemistry. Vevo is backed by leading investors at the intersection of life sciences and technology, including General Catalyst, Wing Venture Capital, Mubadala Capital, AIX Ventures, and Camford Capital. Learn more at www.vevo.ai.